Meeting
2017 Genitourinary Cancers Symposium
Genomic mechanisms of resistance to neoadjuvant leuprolide plus abiraterone in locally advanced prostate cancer.
Authors
Adam G. Sowalsky
National Cancer Institute, Bethesda, MD
Adam G. Sowalsky , Huihui Ye , Rachel J. Schaefer , Olga S. Voznesensky , Zhenwei Zhang , Rosina Lis , Glenn J. Bubley , Mary-Ellen Taplin , Steven P. Balk
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Clinical Trial Registration Number
NCT00924469
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 98)
DOI
10.1200/JCO.2017.35.6_suppl.98
Abstract #
98
Poster Bd #
E9
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Santosh Gupta
Poster
2018 ASCO Annual Meeting
Genomic profiling of primary prostate tumors from patients who develop metastatic castration-resistant prostate cancer (mCRPC).
First Author: Joaquin Mateo
Poster
2020 ASCO Virtual Scientific Program
Clinical, genetic, and pathologic determinants of prostate cancer brain metastasis.
First Author: Mira Patel
Poster
2020 Genitourinary Cancers Symposium
A tale of lineage plasticity: Intense neoadjuvant testosterone lowering therapy in localized prostate cancer (PCa) harboring high-risk genomic signatures.
First Author: Fatima Karzai